Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
8.13
-0.03 (-0.37%)
At close: May 11, 2026, 4:00 PM EDT
8.13
0.00 (0.00%)
After-hours: May 11, 2026, 4:04 PM EDT
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $55.14 million as of May 11, 2026. Its market cap has decreased by -57.13% in one year.
Market Cap
55.14M
Enterprise Value
64.39M
1-Year Change
-57.13%
Ranking
Category
Stock Price
$8.13
Market Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $55.14M, a decrease of -97.81%. That is a compound annual growth rate of -52.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 55.34M | -25.82% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 61.81M |
| BeyondSpring | 61.27M |
| Entera Bio | 60.61M |
| Lixte Biotechnology Holdings | 59.95M |
| ImageneBio | 59.17M |
| Dogwood Therapeutics | 55.11M |
| MiNK Therapeutics | 54.82M |
| Kezar Life Sciences | 53.86M |